Targeting AT1-AA Signaling: A Novel Therapeutic Approach to Reduce Maternal Hypertension and Systemic Complications in Preeclampsia
Morgan Sheppard Background: Preeclampsia is a multisystemic condition which develops after 20 weeks of gestation.1,2 It is identified as new onset hypertension and is frequently accompanies with systemic complications such as proteinuria, eclampsia, acute kidney injury, hepatic injury, and fetal growth restriction.1,2 Preeclampsia is considered the most common cause of…